Terbinafine as a successful treatment in primary cutaneous aspergillosis
Anais Brasileiros de Dermatologia · 2024
DOI: 10.1016/j.abd.2023.07.011 ↗Kurz gefasst
Fallbericht in der Zeitschrift Anais Brasileiros de Dermatologia, 2024. Verfasst von Juan-Manuel Morón-Ocaña und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Virgen de Valme Hospital, Sevilla, Spain. Electronic address: juanm.moron.sspa@juntadeandalucia.es. Hauptthemen laut MEDLINE: Terbinafine, Antifungal Agents, Aspergillosis. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Virgen de Valme Hospital, Sevilla, Spain. Electronic address: juanm.moron.sspa@juntadeandalucia.es.
- Department of Dermatology, Virgen de Valme Hospital, Sevilla, Spain.
Zitieren
APA
Morón-Ocaña, J. M., Coronel-Pérez, I. M., & Rodríguez-Rey, E. M. (2024). Terbinafine as a successful treatment in primary cutaneous aspergillosis. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2023.07.011
Vancouver
Morón-Ocaña JM, Coronel-Pérez IM, Rodríguez-Rey EM. Terbinafine as a successful treatment in primary cutaneous aspergillosis. Anais Brasileiros de Dermatologia. 2024. doi:10.1016/j.abd.2023.07.011
BibTeX
@article{MornOcaa2024,
author = {Morón-Ocaña, Juan-Manuel and Coronel-Pérez, Isabel-María and Rodríguez-Rey, Elena-Margarita},
title = {Terbinafine as a successful treatment in primary cutaneous aspergillosis},
journal = {Anais Brasileiros de Dermatologia},
year = {2024},
doi = {10.1016/j.abd.2023.07.011}
}
EUVIMED